The genetic determinants of recurrent somatic mutations in 43,693 blood genomes

NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Nononcogenic somatic mutations are thought to be uncommon and inconsequential. To test this, we analyzed 43,693 National Heart, Lung and Blood Institute Trans-Omics for Precision Medicine blood whole genomes from 37 cohorts and identified 7131 non-missense somatic mutations that are recurrently mutated in at least 50 individuals. These recurrent non-missense somatic mutations (RNMSMs) are not clearly explained by other clonal phenomena such as clonal hematopoiesis. RNMSM prevalence increased with age, with an average 50-year-old having 27 RNMSMs. Inherited germline variation associated with RNMSM acquisition. These variants were found in genes involved in adaptive immune function, proinflammatory cytokine production, and lymphoid lineage commitment. In addition, the presence of eight specific RNMSMs associated with blood cell traits at effect sizes comparable to Mendelian genetic mutations. Overall, we found that somatic mutations in blood are an unexpectedly common phenomenon with ancestry-specific determinants and human health consequences.

Original languageEnglish (US)
Article numbereabm4945
JournalScience Advances
Volume9
Issue number17
DOIs
StatePublished - Apr 2023

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'The genetic determinants of recurrent somatic mutations in 43,693 blood genomes'. Together they form a unique fingerprint.

Cite this